Home » Topics » Briefs » Other news to note

Other news to note
RSS

Finch Therapeutics and Crestovo merge to form Finch Therapeutics Group

Oct. 24, 2017

Cydan raises funds to support development of drugs for rare genetic diseases

Oct. 20, 2017

Mitsubishi Tanabe Pharma's acquisition of NeuroDerm complete

Oct. 19, 2017

Johnson & Johnson reviews highlights of third quarter 2017

Oct. 19, 2017

AntriaBio selects lead oral plasma kallikrein inhibitor candidates

Oct. 19, 2017

Amneal Pharmaceuticals and Impax Laboratories announce merger

Oct. 18, 2017

Inotek Pharmaceuticals files statement regarding proposed merger with Rocket Pharmaceuticals

Oct. 16, 2017

Recursion in research collaboration agreement with Takeda

Oct. 13, 2017

Astellas, Mitsubishi Tanabe and Daiichi Sankyo establish JOINUS drug repositioning program

Oct. 13, 2017

FDA announces grants for clinical trials and natural history studies

Oct. 9, 2017

Popular Stories

University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Beijing Innocare Pharma Tech discloses new GSPT1 degradation inducers
BioWorld Science
Beijing Innocare Pharma Tech Co. Ltd. has synthesized new antibody-drug conjugates comprising antibody or antigen-binding fragment covalently linked to eukaryotic...